Buscar
Resultados de la búsqueda
- A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer.
-
... Medical Doctor, First degree specialist in oncology Affiliation: National Institute of Oncology and Radiobiology (INOR) Postal ...
Clinical Trials - ROCHE - 31/07/2023 - 11:34am
- Estudio para evaluar la eficacia y la seguridad del tratamiento con quimioterapia más Atezolizumab en pacientes con cáncer de mama triple negativo recurrente recidivante temprano
-
... de funcionamiento del Eastern Cooperative Oncology Group 0-1 7. Esperanza de vida ≥ 12 semanas 8. Función ... instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76. Adams S, Diamond J, Hamilton E, ... for diagnosis, treatment and follow-up. Annals of Oncology 2012;23 (Supplement 7):vii11−vii19. Carey LA, Rugo HS, Marcom PK et ...
Ensayos Clínicos - ROCHE - 31/07/2023 - 11:22am
- Oncoxin-Viusid-Advanced or metastatic ovarian epithelial cancer-Adult women-Phase II
-
... 1st Grade Specialist in Oncology Affiliation: National Institute of Oncology and Radiobiology (INOR) Postal ...
Clinical Trials - CATALYSIS - 19/07/2023 - 3:02pm
- Oncoxin-Viusid-Cáncer epitelial de ovario avanzado o metastásico- Mujeres adultas-Fase II
-
... M, Randall ME, eds. Principles and Practice of Gynecologic Oncology, 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013: ... Rosenberg SA (Eds.) Cancer: Principles & Practice of Oncology. 7th Edition. Philadelphia: Lippincott Williams & Wilkins; 2005. ...
Ensayos Clínicos - CATALYSIS - 19/07/2023 - 3:00pm
- Oncoxin®-Viusid®- Quality of life of patients with metastatic colorectal adenocarcinoma-adults-Phase II
-
... First degree Specialist in Clinical Oncology Affiliation: National Institute of Oncology and Radiobiology (INOR) Postal ...
Clinical Trials - CATALYSIS - 19/07/2023 - 2:59pm
- Oncoxin-Viusid / Pancreatic adenocarcinoma / Adults / Phase II
-
... 2nd grade specialist in Clinical Oncology Affiliation: ... 2nd grade specialist in Clinical Oncology Affiliation: ...
Clinical Trials - CATALYSIS - 19/07/2023 - 2:59pm
- Vaxira as adjuvant treatment for non-small cell lung cancer
-
... National Institute of Oncology and Radiobiology (INOR) Secondary ... National Institute of Oncology and Radiobiology (INOR) Postal ...
Clinical Trials - CIM - 19/07/2023 - 2:57pm
- CIMAvax-EGF vaccine Predictor Phase IV
-
... MD, First degree specialist in Oncology Affiliation: ... , Juan Carlos Brosales, MD, First Degree Especilist in Oncology Havana, Luis Galván ...
Clinical Trials - CIM - 19/07/2023 - 2:32pm
- Vacuna CIMAvax-EGF Predictor fase IV
-
... NCCN Clinical Practice Guidelines in Oncology. NSCLC. Version I. 2013 www.nccn.org ...
Ensayos Clínicos - CIM - 19/07/2023 - 2:32pm
- 1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma
-
... MD. Second degree specialist in Oncology, INOR MD. Second degree specialist in Hematology, HHA ... Havana, National Institute of Oncology and Radiobiology (INOR) Havana, “Hermanos Ameijeiras” Hospital ...
Clinical Trials - CIM - 19/07/2023 - 2:32pm